InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,186.33
(
-3.00%
)
US TECH 100
17,653.20
(
-1.65%
)
Dow Jones
38,703.27
(
-2.60%
)
Brent Oil
77.25
(
0.11%
)
Bitcoin
55,735.61
(
3.23%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Shotime66

Send PM Follow Ignore
Followers 34
Posts 1017
Boards Moderated 0
Alias Born 12/09/2013

Shotime66

Re: Crocs69 post# 148155

Wednesday, 01/14/2015 10:18:27 AM

Wednesday, January 14, 2015 10:18:27 AM

Post# of 158400
They are working side by side with open dialogue regarding getting trials worked out and who (BIG Pharm)may be wanting to buy in... I'm sure Ichim will not settle for second best. They are working to produce true results and methods of treatment that will be game changing... JMO GLTA


"We are grateful for the examiners at the FDA to have taken the time to walk us through their thinking and explaining to us what they believe will add the greatest level of safety to our HemaXellerate product. By closely working with the FDA now, we believe the path for future trials, including other disease indications will be much smoother," said Thomas Ichim, PhD, Chief Scientific Officer of Regen BioPharma Inc.




BMSN/RGBP$$$$$$$$$$

All opinions are my own. "I earn money the hard way,,,, I work for it"

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up